Local 12: Report: Person was 'cured' of HIV, but a local doctor says treatment is dangerous
UC expert has concerns about stem cell transplants
New research published in the Nature Medicine journal says a 53-year-old German man is now clear of HIV after a procedure that replaced his bone marrow cells with HIV-resistant stem cells from a donor. He is just the third person to be cured of HIV.
WKRC-TV, Local 12, interviewed Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the University of Cincinnati College of Medicine, who was at the scientific meeting in Seattle where this research was released.
"I do hope in my professional lifetime will be able to see him the situation where we can cure a disease like HIV,” said Fichtenbaum. "Every year, we get a little bit closer to a better answer.”
/content/dam/uc/news/ahc-public-relations/medicine/fichtenbaum-lab-folder.jpg/Photo/Colleen Kelley/UC Marketing + Brand
While the news about the German patient is exciting, Fichtenbaum knows it doesn't do much for the average person living with the virus.
"It’s very important, it gives us hope, but it’s not a scalable cure that can be down at your local pharmacy tomorrow," said Fichtenbaum.
That is mostly because of how specific the patient's health condition is and because Fichtenbaum says operations like stem cell transplants are extremely dangerous.
"We have tried this several times and it’s failed because bone marrow transplant transplants, stem cell transplants are dangerous, and these are mostly used in individuals who have cancer,” said Fichtenbaum.
Lead photo/Aaron Ufumeli/EPA-EFE
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
6 ways starting a GLP-1 medication could affect your emotions
May 20, 2026
When patients first start taking a glucagon-like peptide-1 (GLP-1) medication, they probably expect to feel full. But they might not anticipate how it can influence their emotions. The medications act on the stomach and the brain, said Malti Vij, MD, a University of Cincinnati adjunct associate professor in the College of Medicine's Department of Internal Medicine and a diplomate of the American Board of Obesity Medicine.
UC researchers recruit older adults for extreme heat health study
May 20, 2026
The University of Cincinnati’s Center for Collaboration on Climate & Community for Health (C4H) is recruiting older adults to participate in a study tracking their health during periods of extreme summer heat.
$15 million bequest supports endowed chair at UC College of Medicine
May 19, 2026
As a student and resident at the University of Cincinnati College of Medicine, George G. Bemis, Jr., MD, Med ’64, saw firsthand that medicine was more than a profession for those teaching and leading him. Inspired by their sense of calling, he knew he wanted to pursue the same path.